S7 TFA
S7 is a peptide antagonist of the IL-6 receptor that inhibits IL-6 binding and signaling. It reduces VEGF in cancer cell lines, suppresses tumor growth in cervical cancer xenografts, and enhances targeted drug delivery to gliomas when conjugated to doxorubicin-loaded nanoparticles.
Product Specifications
Field of Research
Immunology & Inflammation
Molecular Weight
815.01
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog